Pain, Postoperative | Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial

Pain, Postoperative research study

What is the primary objective of this study?

The purpose of this study is to determine whether using an additional 48 hours of oral naproxen, after other post-operative pain medications have been stopped, will be effective in reducing opiate pain medication requirements and contribute to improved pain management.

Who is eligible to participate?

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Pain, Postoperative

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:naproxenopaque pale orange suspension: 20mL q12h x 4 doses mixed in juice.

Drug:placeboopaque pale orange suspension: 20mL q12h x 4 doses mixed in juice

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.



Study Status

Unknown status

Start Date: March 2008

Completed Date: June 2008

Phase: Phase 4

Type: Interventional


Primary Outcome: cumulative opiate dose administered, as recorded on the computerized medication administration record (CMAR)

Secondary Outcome: patient reported pain scores

Study sponsors, principal investigator, and references

Principal Investigator: Tuan Dinh, RPh

Lead Sponsor: Hamilton Health Sciences Corporation


More information:

Starck PL, Sherwood GD, Adams-McNeill J, Thomas EJ. Identifying and addressing medical errors in pain mismanagement. Jt Comm J Qual Improv. 2001 Apr;27(4):191-9. Review.

Discuss Aleve